TA-1 (Thymosin Alpha-1)

What Is Thymosin Alpha‑1?

Thymosin Alpha‑1 (Tα1) is a synthetic peptide corresponding to a naturally occurring thymic hormone fragment. It was first isolated from thymus tissue and developed as an immunomodulatory agent with broad applications in immune system regulation. Tα1 has been studied for its ability to enhance host defense mechanisms, making it relevant in infectious disease, oncology, and immunodeficiency research.

Mechanism of Action

Thymosin Alpha‑1 acts by stimulating T‑cell differentiation and activation, enhancing the function of cytotoxic T lymphocytes and natural killer (NK) cells. It modulates cytokine production, including increased interferon‑γ and interleukin‑2, while reducing pro‑inflammatory cytokines. This dual activity strengthens immune surveillance against pathogens and tumor cells while balancing immune responses to prevent excessive inflammation. Tα1 also influences antigen presentation and supports adaptive immunity.

Research & Clinical Data

Clinical studies have investigated Thymosin Alpha‑1 in viral infections (such as hepatitis B and C), sepsis, and as an adjunct in cancer immunotherapy. It has been approved in some countries for chronic hepatitis B and C treatment, often in combination with interferon therapy. Research also explores its role in vaccine adjuvancy, immune restoration in immunocompromised patients, and potential benefits in emerging viral diseases. Side effects are generally mild, including injection site reactions and transient flu‑like symptoms. Regulatory approval varies by region, with investigational use continuing globally.

Purity & Quality

Pharmaceutical‑grade peptide material. Certificate of Analysis available per batch. Regulatory status: approved in select countries for hepatitis; investigational elsewhere.

Classification & Handling Class: Synthetic thymic peptide | Source: Thymus hormone analog | Administration: Subcutaneous injection | Storage: 2–8°C refrigerated, protect from light | Regulatory: Regionally approved, investigational globally